Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy

NCT02918409 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.

NCT NCT02918409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02918409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy
Lead sponsor
National Jewish Health
Phase
Phase 4
Overall status
Completed
Start date
August 26, 2016
Completion date
November 22, 2021
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis